1. Blog

ApoB in one page: what it measures and who should ask

Apolipoprotein B (ApoB) is a protein found on every particle that can carry cholesterol into the artery wall. Each of these particles has exactly one ApoB, so the test counts them . LDL cholesterol measures how much cholesterol those particles carry.…

7 min de lectura

En este artículo
  1. What ApoB measures
  2. Why ApoB can say more than LDL
  3. How ApoB is measured
  4. Who should ask for ApoB
  5. ApoB at Santé Labs
  6. FAQ

Apolipoprotein B (ApoB) is a protein found on every particle that can carry cholesterol into the artery wall. Each of these particles has exactly one ApoB, so the test counts them [1]. LDL cholesterol measures how much cholesterol those particles carry. In about 1 in 5 people the two results may point in different directions [1].

Key takeaways

  • ApoB estimates the number of atherogenic particles in your blood, because each one carries a single ApoB molecule [1].
  • LDL cholesterol and ApoB usually agree, but European guidelines estimate they disagree in around 20% of patients [1].
  • Disagreement is more common with high triglycerides, diabetes, obesity or very low LDL cholesterol [1][2].
  • ApoB is a standard blood test. You do not need to fast for it [1][2].
  • ApoB is not yet available at Santé Labs. Discuss whether it is useful for you with your doctor.

What ApoB measures

Cholesterol does not float freely in blood. It travels inside particles called lipoproteins. The main ones that can enter and stay in the artery wall are LDL, VLDL, IDL and lipoprotein(a). All of them carry one molecule of ApoB [1].

That one-to-one link is the key idea. If you measure ApoB, you are effectively counting atherogenic particles [1]. The European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) describe LDL and other ApoB-containing particles as a cause of atherosclerotic cardiovascular disease, based on genetic, epidemiological and clinical trial evidence [1][3].

LDL particles make up the large majority of ApoB particles in most people. That is why LDL cholesterol and ApoB often track each other closely.

Why ApoB can say more than LDL

LDL cholesterol (LDL-C) tells you how much cholesterol is inside LDL particles. It does not tell you how many particles there are.

Two people can have the same LDL-C. One may have fewer particles packed with cholesterol. The other may have many smaller particles, each carrying less. The second person has a higher ApoB, and the guidelines say LDL-C may underestimate their risk in that case [1].

How often the two disagree

The 2019 ESC/EAS guidelines state that in around 20% of patients there may be discordance between LDL-C and ApoB [1]. They list the groups where this is more likely: people with high triglycerides, diabetes, obesity, and people whose LDL-C is already very low [1].

A 2024 analysis of 12,688 US adults not taking statins found that ApoB ran higher than expected for a given LDL-C more often in people with metabolic risk factors. It also found this in some metabolically healthy people [4]. The authors argued that testing only people with high triglycerides may be too narrow [4].

What the wider evidence says

A 2011 meta-analysis pooled 12 studies with 233,455 participants and 22,950 cardiovascular events. ApoB was the strongest of the three markers studied, followed by non-HDL cholesterol and then LDL-C [5]. An individual-patient analysis of statin trials, published in 2012, found that all three were linked to future events during treatment. In that analysis, non-HDL cholesterol showed the strongest link [6]. The evidence points the same way overall, but studies differ on the size of the advantage.

The US National Lipid Association concluded in 2024 that when ApoB and LDL-C disagree, cardiovascular risk generally aligns better with ApoB or non-HDL cholesterol [7].

How ApoB is measured

ApoB is measured from a standard blood sample. The ESC/EAS guidelines note that standardised, automated and inexpensive methods are available, and that their analytical performance is better than the measurement or calculation of LDL-C [1].

Fasting is not required. Even after a meal, the ApoB particles that come from food represent less than 1% of the total [1]. A Spanish consensus for clinical laboratories also states that ApoB values are not affected by fasting [2].

Results are reported in mg/dL in most guidelines. Some laboratories in Spain report g/L, where 65 mg/dL equals 0.65 g/L.

Targets used in guidelines

ApoB does not have one universal "normal" value. Reference ranges vary between laboratories, and population values differ by sex and age. Guidelines instead set goals according to each person's overall cardiovascular risk, which a doctor estimates.

Risk category (assessed by your doctor) ApoB goal in guidelines Source Caveat
Very high risk below 65 mg/dL ESC/EAS 2019 [1]; Spanish lab consensus [2] A secondary goal, after LDL-C
High risk below 80 mg/dL ESC/EAS 2019 [1]; Spanish lab consensus [2] A secondary goal, after LDL-C
Moderate risk below 100 mg/dL ESC/EAS 2019 [1]; Spanish lab consensus [2] A secondary goal, after LDL-C
Low risk No ApoB goal set Spanish lab consensus [2] Your lab's reference range applies

The ESC/EAS give these ApoB goals a moderate grading because they have not been widely tested in randomised trials [1]. They are goals for people under medical follow-up, not cut-offs for self-diagnosis. Your report will show your laboratory's own reference range. Discuss what your result means with your doctor.

Who should ask for ApoB

Guidelines do not recommend ApoB for everyone in the same way. The ESC/EAS 2019 guidelines and the Spanish laboratory consensus point to these groups [1][2]:

  • People with high triglycerides.
  • People with diabetes, obesity or metabolic syndrome.
  • People whose LDL-C is already very low, for example on treatment.
  • People who want a fuller picture of risk that LDL-C alone may miss.

The Spanish consensus adds that ApoB is not necessary to diagnose familial hypercholesterolaemia [2]. The 2024 US analysis suggests some people outside these groups also have ApoB higher than their LDL-C suggests [4].

If you fit one of these groups, ask your doctor whether ApoB would add useful information in your case.

ApoB at Santé Labs

ApoB is not yet available at Santé Labs. The Standard Lipid Profile, with total cholesterol, HDL, LDL, triglycerides and the atherogenic index, is coming soon. It does not include ApoB or Lp(a).

Bookable now in Barcelona, the Glycaemic Control Profile includes total cholesterol, HDL, LDL and triglycerides alongside glucose, HbA1c, creatinine and eGFR. It does not include ApoB.

Santé Labs measures and explains your results. Please discuss them with your doctor.

FAQ

Is ApoB the same as LDL cholesterol?

No. LDL-C measures the cholesterol inside LDL particles. ApoB counts the particles themselves, including LDL, VLDL, IDL and Lp(a) [1].

Do I need to fast for an ApoB test?

No. Guidelines and the Spanish laboratory consensus state that fasting does not meaningfully affect ApoB [1][2].

What is a normal ApoB?

There is no single value for everyone. Reference ranges vary by laboratory, sex and age. Guidelines set goals by cardiovascular risk, from below 100 mg/dL for moderate risk to below 65 mg/dL for very high risk [1]. Your doctor can tell you which applies to you.

My LDL is normal. Can my ApoB still be high?

Yes, it can happen. This is more common with high triglycerides, diabetes or obesity, but it is also seen in some metabolically healthy people [1][4]. Discuss a discordant result with your doctor.

Is ApoB the same as Lp(a)?

No. Lp(a) is one type of ApoB-containing particle, mostly set by genetics. ApoB counts all atherogenic particles, Lp(a) included [1]. They are separate tests.

Can I book ApoB at Santé Labs today?

Not yet. ApoB is not part of any profile you can book with us today.

References

  1. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188 – https://academic.oup.com/eurheartj/article/41/1/111/5556353
  2. Arrobas Velilla T, et al. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Clin Investig Arterioscler. 2023;35:91-100 – https://www.elsevier.es/en-revista-clinica-e-investigacion-arteriosclerosis-english-415-articulo-consensus-document-for-lipid-profile-S2529912323000177
  3. Borén J, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313-2330 – https://doi.org/10.1093/eurheartj/ehz962
  4. Sayed A, et al. Individual variation in the distribution of apolipoprotein B levels across the spectrum of LDL-C or non-HDL-C levels. JAMA Cardiol. 2024;9(8):741-747 – https://doi.org/10.1001/jamacardio.2024.1310
  5. Sniderman AD, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337-345 – https://doi.org/10.1161/CIRCOUTCOMES.110.959247
  6. Boekholdt SM, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307(12):1302-1309 – https://doi.org/10.1001/jama.2012.366
  7. Soffer DE, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association. J Clin Lipidol. 2024 – https://doi.org/10.1016/j.jacl.2024.08.013
Compartir

Plan Superhuman

Mide tu ApoB.Y más de 100 biomarcadores en total.

Una analítica completa al año en el laboratorio y un plan de acción claro.

495 € al año, con renovación anual. Cancela la renovación desde la app. Si tu médico no aprueba la solicitud, te devolvemos todo lo pagado. La lista exacta depende de tu sexo y tu edad.

Sigue leyendo

Artículos relacionados.Para leer junto a este.

Ver el blog
Ver el blog